Preparation of Immunocompromised Travelers

Travel Medicine: Second Edition

Volumn , Issue , 2008, Pages 257-264

  Hicks, Lauri A ^a   Mileno, Maria D ^b,c  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883917951     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03453-1.10025-2     Document Type: Chapter

References (41)

1. Liesch Z., Hanck C., Werth B., et al. Diarrhea and weight loss in common variable immunodeficiency. Z Gastroenterol 2004, 42:599-603.
2. Onbasi K., Gunsar F., Sin A.Z., et al. Common variable immunodeficiency (CVID) presenting with malabsorption due to giardiasis. Turk J Gastroenterol 2005, 16:111-113.
3. de Moraes-Vasconcelos D., Grumach A.S., Yamaguti A., et al. Paracoccidioides brasiliensis disseminated disease in a patient with inherited deficiency in the β1 subunit of the interleukin (IL)-12/IL-23 receptor. Clin Infect Dis 2005, 41:e31-e37.
4. Zerbe C.S., Holland S.M. Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency. Clin Infect Dis 2005, 41:e38-e41.
5. Centers for Disease Control and Prevention The immunocompromised traveler. In: Health information for international travel 2005-2006 2005, US Department of Health and Human Services, Public Health Service, Atlanta.
6. Mileno M.D. Occupational HIV Exposure. Med Health RI 2000, 83:207-210.
7. Atkinson W.L., Pickering L.K., Schwartz B., et al. General Recommendations on Immunization. Recommendations of the Advisory Committee on Immunization Practice (ACIP) and the American Academy of Family Physicians (AAFP). MMWR 2002, 51(RR-2):1-36.
8. McDonald E., Jarrell M.P., Schiffman G., et al. Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus. J Rheumatol 1984, 11:306-308.
9. Keane J., Gershon S., Wise R.P., et al. Tuberculosis associated with Infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 2001, 345:1098-1104.
10. Filler S.G., Yeaman M.R., Sheppard D.C. Tumor necrosis factor inhibition and invasive fungal infections. Clin Infect Dis 2005, 41:S187-S217.
11. O'Neal B.J., McDonald J.C. The risk of sepsis in the asplenic adult. Ann Surg 1981, 194:775-778.
12. Lynch A.M., Kapila R. Overwhelming postsplenectomy infection. Infect Dis Clin North Am 1996, 10:693-707.
13. Conlon C.P. Travel and the immunocompromised host. Hosp Med 2000, 61:167-170.
14. Kobel D.E., Friedel A., Cerny T., et al. Pneumococcal vaccine in patients with absent or dysfunctional spleen. Mayo Clinic Proc 2000, 75:749-753.
15. Hoban D.J., Doern G.V., Fluit A.C., et al. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001, 32:S81-S93.
16. Styrt B.A. Risks of infection and protective strategies for the asplenic patient. Infect Dis Clin Pract 1996, 5:94-100.
17. Malesker M.A., Boken D., Ruma T.A., et al. Rhodesian trypanosomiasis in a splenectomized patient. Am J Trop Med Hyg 1999, 61:428-430.
18. Shankar V.K., Zilvetti M., Handa A., et al. Chronic diarrhea and weight loss due to Vibrio parahaemolyticus infection in a renal transplant recipient. Transplantation 2004, 78(3):487.
19. Suh K.N., Mileno M.D. Challenging scenarios in a travel clinic: advising the complex traveler. Infect Dis Clin North Am 2005, 19(1):15-47.
20. Boggild A.K., Sano M., Humar A., et al. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med 2004, 11:37-43.
21. Golan Y. Overview of transplant mycology. Am J Health-Syst Pharm 2005, 62:S17-S21.
22. Baddley J.W., Stroud T.P., Salzman D., et al. Invasive mold infections in allogenic bone marrow transplant recipients. Clin Infect Dis 2001, 32:1319-1324.
23. Fischer M.A., Winkelmayer W.C., Rubin R.H., et al. The hepatoxicity of antifungal medications in bone marrow transplant recipients. Clin Infect Dis 2005, 41:301-307.
24. Nguyen O., Estey E., Ruad I., et al. Cytomegalovirus pneumonia in adults with leukemia: an emerging problem. Clin Infect Dis 2001, 32:539-545.
25. Paya C.V. Prevention of cytomegalovirus disease in recipients of solid-organ transplants. Clin Infect Dis 2001, 32:596-603.
26. LaRosa A.M., Champlin R.E., Mirza N., et al. Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis 2001, 32:871-876.
27. Dykewicz C.A. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001, 33:139-144.
28. Gowda R., Cartwright K., Bremner J.A., Green S.T. Yellow fever vaccine: a successful vaccination of an immunocompromised patient. Eur J Haematol 2004, 72:299-301.
29. Rolston K.V., Wingard J.R. Managing infections in patients with hematologic malignancies 2003, Academy of Healthcare Education, New York, 1-22.
30. Blumberg E.A., Brozena S.C., Stutman P., et al. Immunogenicity of pneumococcal vaccine in heart transplant recipients. Clin Infect Dis 2001, 32:307-310.
31. Burroughs M., Moscona A. Immunization of pediatric solid organ transplant candidates and recipients. Clin Infect Dis 2000, 30:857-869.
32. Blumberg E.A., Fitzpatrick J., Stutman P.C., et al. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998, 17:1075-1080.
33. Kofidis T., Pethig K., Ruther G., et al. Traveling after heart transplantation. Clin Transplant 2002, 16(4):280-284.
34. Stark K., Gunther M., Neuhaus R., et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 1999, 180:2014-2017.
35. Avery R.K., Dumot J. Hepatitis A vaccine in liver transplant recipients [Correspondence]. Clin Infect Dis 2001, 32:1656-1657.
36. McNeil M.M., Nash S.L., Hajjeh R.A., et al. Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997. Clin Infect Dis 2001, 33:641-647.
37. Kontoyiannis D.P., Peitsch W.K., Reddy B.T., et al. Cryptococcosis in patients with cancer. Clin Infect Dis 2001, 32:45-50.
38. Hay E., Derazon H., Bukish N., et al. Rabies prophylaxis in a patient with lymphoma. JAMA 2001, 285:166-167.
39. DuPont H.L., Jiang Z., Ericsson C.D., et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis 2001, 33:1807-1815.
40. Huang D.B., DuPont H.L. Rifaximin - a novel antimicrobial for enteric infections. J Infect 2005, 50:97-106.
41. Mutsch M., Tavernini M., Marx A., et al. Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis 2005, 40:1282-1287.